Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Incyte Corporation
Incyte Corporation
Dren Bio
AVM Biotechnology Inc
Arovella Therapeutics Ltd
CRISPR Therapeutics
AstraZeneca
AvenCell Therapeutics, Inc.
Vironexis Biotherapeutics Inc.
Pfizer
Fate Therapeutics
Syndax Pharmaceuticals
Incyte Corporation
Allogene Therapeutics
BeOne Medicines
Ossium Health, Inc.
Ossium Health, Inc.
GeoVax, Inc.
Incyte Corporation
Adela, Inc
AstraZeneca
Acerta Pharma BV
AbbVie
First Ascent Biomedical Inc.
AbbVie
Kura Oncology, Inc.
Massive Bio, Inc.
CRISPR Therapeutics
Incyte Corporation
Biotroy Therapeutics
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Cogent Biosciences, Inc.
Amgen
Tempus AI
Genmab
Ono Pharmaceutical Co. Ltd
Zhejiang DTRM Biopharma
Acerta Pharma BV
Pharmacyclics LLC.
Munich Leukemia Laboratory
Munich Leukemia Laboratory
Takara Bio Inc.
Vincerx Pharma, Inc.
Xencor, Inc.
BeiGene
Servier
GlaxoSmithKline
Cyclacel Pharmaceuticals, Inc.
Pfizer
OrphAI Therapeutics
Celgene